Capital International Sarl’s Integra LifeSciences IART Stock Holding History

Capital International Sarl’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-37,725	Closed	-$2.2M	–	235
2019 Q4	$2.2M	Hold	37,725	–	–	0.34%	92
2019 Q3	$2.27M	Sell	37,725 -36,600	-49%	-$2.18M	0.39%	79
2019 Q2	$4.15M	Hold	74,325	–	–	0.58%	59
2019 Q1	$4.14M	Sell	74,325 -13,300	-15%	-$677K	0.52%	62
2018 Q4	$3.95M	Buy	87,625 +12,025	+16%	+$660K	0.48%	67
2018 Q3	$4.98M	Buy	+75,600	New	+$4.7M	0.47%	73

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Capital International Sarl's IART Position: Q1 2020 in Review

Capital International Sarl sold out of Integra LifeSciences (IART) in Q1 2020, closing a stake of 37,725 shares — an estimated $2.2M sold.

Capital International Sarl first reported a position in IART in Q3 2018 and held it in 6 quarters. The position peaked at $4.98M in Q3 2018. 258 funds tracked by Wall St. Rank hold IART as of Q1 2020.

Capital International Sarl reported no remaining Integra LifeSciences position as of Q1 2020 after selling out during the quarter.
Capital International Sarl sold 37,725 Integra LifeSciences shares in Q1 2020, an estimated $2.2M.
Capital International Sarl first reported a position in Integra LifeSciences in Q3 2018 and held it in 6 quarters.
Capital International Sarl's Integra LifeSciences position peaked at $4.98M in Q3 2018.
258 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2020.

Based on Capital International Sarl's 13F filing for Q1 2020, filed 15 May 2020.